RegulatoryMay 29, 2026, 05:16 PM
Celularity Receives Nasdaq Non-Compliance Notice for Delayed 10-Q Filing
AI Summary
Celularity Inc. announced it received a notification from Nasdaq on May 27, 2026, indicating non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2026. This notification does not immediately impact the trading of its common stock. Nasdaq has given the company 60 days, until July 28, 2026, to submit a plan to regain compliance, with a potential extension until November 16, 2026. Celularity is working to file the 10-Q promptly.
Key Highlights
- Celularity received a Nasdaq non-compliance notification on May 27, 2026.
- The non-compliance is due to the delayed filing of its Quarterly Report on Form 10-Q for Q1 2026.
- The company violated Nasdaq Listing Rule 5250(c)(1) requiring timely periodic financial reports.
- Nasdaq provided a 60-day period, until July 28, 2026, to submit a compliance plan.
- If accepted, Nasdaq may grant an extension of up to 180 days, until November 16, 2026.
- The company is actively working to file its Form 10-Q as soon as practicable.
Price Impact
More from CELU